{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:38:30Z","timestamp":1792712310351,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77546-5","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:03:16Z","timestamp":1790179396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neoadjuvant chemotherapy interferes with tertiary lymphoid structure formation in Epstein-Barr virus-associated gastric cancer"],"prefix":"10.1038","volume":"17","author":[{"given":"Jiwang","family":"Bi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9922-5311","authenticated-orcid":false,"given":"Shuofeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3024-0331","authenticated-orcid":false,"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqian","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinya","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6126-7372","authenticated-orcid":false,"given":"Xiaomin","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6878-5543","authenticated-orcid":false,"given":"Jiafu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"77546_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"77546_CR2","doi-asserted-by":"publisher","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202\u2013209 https:\/\/doi.org\/10.1038\/nature13480 (2014).","DOI":"10.1038\/nature13480"},{"key":"77546_CR3","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1053\/j.gastro.2009.05.001","volume":"137","author":"G Murphy","year":"2009","unstructured":"Murphy, G., Pfeiffer, R., Camargo, M. C. & Rabkin, C. S. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology 137, 824\u2013833 https:\/\/doi.org\/10.1053\/j.gastro.2009.05.001 (2009).","journal-title":"Gastroenterology"},{"key":"77546_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.19723\/j.issn.1671-167X.2019.03.012","volume":"51","author":"Y Yang","year":"2019","unstructured":"Yang, Y. et al. Clinicopathological and molecular characteristics of Epstein-Barr virus associated gastric cancer: a single center large sample case investigation. J. Peking. Univ. 51, 451\u2013458 https:\/\/doi.org\/10.19723\/j.issn.1671-167X.2019.03.012 (2019).","journal-title":"J. Peking. Univ."},{"key":"77546_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.586752","volume":"10","author":"X Jia","year":"2020","unstructured":"Jia, X. et al. Clinicopathological and immunomicroenvironment characteristics of Epstein-Barr virus-associated gastric cancer in a Chinese population. Front. Oncol. 10, 586752 https:\/\/doi.org\/10.3389\/fonc.2020.586752 (2020).","journal-title":"Front. Oncol."},{"key":"77546_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham, D. et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N. Engl. J. Med. 355, 11\u201320 https:\/\/doi.org\/10.1056\/NEJMoa055531 (2006).","journal-title":"N. Engl. J. Med."},{"key":"77546_CR7","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","volume":"29","author":"M Ychou","year":"2011","unstructured":"Ychou, M. et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J. Clin. Oncol. 29, 1715\u20131721 https:\/\/doi.org\/10.1200\/JCO.2010.33.0597 (2011).","journal-title":"J. Clin. Oncol."},{"key":"77546_CR8","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"SE Al-Batran","year":"2019","unstructured":"Al-Batran, S. E. et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. Lancet 393, 1948\u20131957 https:\/\/doi.org\/10.1016\/S0140-6736(18)32557-1 (2019).","journal-title":"Lancet"},{"key":"77546_CR9","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1200\/jco.20.02914","volume":"39","author":"YK Kang","year":"2021","unstructured":"Kang, Y. K. et al. PRODIGY: a phase III study of neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery and adjuvant S-1 versus surgery and adjuvant S-1 for resectable advanced gastric cancer. J. Clin. Oncol. 39, 2903\u20132913 https:\/\/doi.org\/10.1200\/jco.20.02914 (2021).","journal-title":"J. Clin. Oncol."},{"key":"77546_CR10","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/s1470-2045(21)00297-7","volume":"22","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial. Lancet Oncol. 22, 1081\u20131092 https:\/\/doi.org\/10.1016\/s1470-2045(21)00297-7 (2021).","journal-title":"Lancet Oncol."},{"key":"77546_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13045-024-01536-7","volume":"17","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II\/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial. J. Hematol. Oncol. 17, 17 https:\/\/doi.org\/10.1186\/s13045-024-01536-7 (2024).","journal-title":"J. Hematol. Oncol."},{"key":"77546_CR12","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1634\/theoncologist.2020-0037","volume":"25","author":"S Corallo","year":"2020","unstructured":"Corallo, S. et al. Clinical behavior and treatment response of Epstein-Barr virus-positive metastatic gastric cancer: implications for the development of future trials. Oncologist 25, 780\u2013786 https:\/\/doi.org\/10.1634\/theoncologist.2020-0037 (2020).","journal-title":"Oncologist"},{"key":"77546_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s10120-023-01445-7","volume":"27","author":"EJ Kim","year":"2024","unstructured":"Kim, E. J. et al. Clinical outcomes of Epstein-Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet chemotherapy. Gastric Cancer. 27, 146\u2013154 https:\/\/doi.org\/10.1007\/s10120-023-01445-7 (2024).","journal-title":"Gastric Cancer."},{"key":"77546_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.611676","volume":"11","author":"T Xie","year":"2021","unstructured":"Xie, T. et al. Clinicopathological characteristics and response to chemotherapy in treatment-naive Epstein-Barr virus associated gastric cancer: a retrospective study. Front. Oncol. 11, 611676 https:\/\/doi.org\/10.3389\/fonc.2021.611676 (2021).","journal-title":"Front. Oncol."},{"key":"77546_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/cjp2.137","volume":"5","author":"M Kohlruss","year":"2019","unstructured":"Kohlruss, M. et al. Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability. J. Pathol. Clin. Res. 5, 227\u2013239 https:\/\/doi.org\/10.1002\/cjp2.137 (2019).","journal-title":"J. Pathol. Clin. Res."},{"key":"77546_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920937434","volume":"12","author":"MZ Qiu","year":"2020","unstructured":"Qiu, M. Z. et al. Observational cohort study of clinical outcome in Epstein-Barr virus associated gastric cancer patients. Ther. Adv. Med. Oncol. 12, 1758835920937434 https:\/\/doi.org\/10.1177\/1758835920937434 (2020).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"77546_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf9419","volume":"375","author":"TN Schumacher","year":"2022","unstructured":"Schumacher, T. N. & Thommen, D. S. Tertiary lymphoid structures in cancer. Science 375, eabf9419 https:\/\/doi.org\/10.1126\/science.abf9419 (2022).","journal-title":"Science"},{"key":"77546_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","volume":"19","author":"WH Fridman","year":"2022","unstructured":"Fridman, W. H. et al. B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome. Nat. Rev. Clin. Oncol. 19, 441\u2013457 https:\/\/doi.org\/10.1038\/s41571-022-00619-z (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"77546_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jhep.2018.09.003","volume":"70","author":"J Calderaro","year":"2019","unstructured":"Calderaro, J. et al. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma. J. Hepatol. 70, 58\u201365 https:\/\/doi.org\/10.1016\/j.jhep.2018.09.003 (2019).","journal-title":"J. Hepatol."},{"key":"77546_CR20","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jhep.2021.10.030","volume":"76","author":"GY Ding","year":"2022","unstructured":"Ding, G. Y. et al. Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma. J. Hepatol. 76, 608\u2013618 https:\/\/doi.org\/10.1016\/j.jhep.2021.10.030 (2022).","journal-title":"J. Hepatol."},{"key":"77546_CR21","doi-asserted-by":"publisher","unstructured":"Long, S. et al. Spatial patterns and MRI-based radiomic prediction of high peritumoral tertiary lymphoid structure density in hepatocellular carcinoma: a multicenter study. J. Immunother. Cancer 12, https:\/\/doi.org\/10.1136\/jitc-2024-009879 (2024).","DOI":"10.1136\/jitc-2024-009879"},{"key":"77546_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217178","volume":"601","author":"H Huang","year":"2024","unstructured":"Huang, H. et al. Survival benefit and spatial properties of tertiary lymphoid structures in esophageal squamous cell carcinoma with neoadjuvant therapies. Cancer Lett. 601, 217178 https:\/\/doi.org\/10.1016\/j.canlet.2024.217178 (2024).","journal-title":"Cancer Lett."},{"key":"77546_CR23","doi-asserted-by":"publisher","unstructured":"Wang, Y. Q. et al. Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study. J. Immunother. Cancer 12, https:\/\/doi.org\/10.1136\/jitc-2023-008613 (2024).","DOI":"10.1136\/jitc-2023-008613"},{"key":"77546_CR24","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1136\/gutjnl-2022-328697","volume":"72","author":"GS Kinker","year":"2023","unstructured":"Kinker, G. S. et al. Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas. Gut 72, 1927\u20131941 https:\/\/doi.org\/10.1136\/gutjnl-2022-328697 (2023).","journal-title":"Gut"},{"key":"77546_CR25","doi-asserted-by":"publisher","unstructured":"Groen-van Schooten, T. S. et al. Mapping the complexity and diversity of tertiary lymphoid structures in primary and peritoneal metastatic gastric cancer. J. Immunother. Cancer 12, https:\/\/doi.org\/10.1136\/jitc-2024-009243 (2024).","DOI":"10.1136\/jitc-2024-009243"},{"key":"77546_CR26","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","volume":"42","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis. Cancer Cell 42, 1370\u20131385.e1379 https:\/\/doi.org\/10.1016\/j.ccell.2024.07.006 (2024).","journal-title":"Cancer Cell"},{"key":"77546_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101934","volume":"6","author":"F Peyraud","year":"2025","unstructured":"Peyraud, F. et al. Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures. Cell Rep. Med. 6, 101934 https:\/\/doi.org\/10.1016\/j.xcrm.2025.101934 (2025).","journal-title":"Cell Rep. Med."},{"key":"77546_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk8805","volume":"10","author":"AM Xu","year":"2024","unstructured":"Xu, A. M. et al. Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma. Sci. Adv. 10, eadk8805 https:\/\/doi.org\/10.1126\/sciadv.adk8805 (2024).","journal-title":"Sci. Adv."},{"key":"77546_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202410998","volume":"12","author":"J Lin","year":"2025","unstructured":"Lin, J. et al. Tertiary lymphoid structures are linked to enhanced antitumor immunity and better prognosis in muscle-invasive bladder cancer. Adv. Sci. 12, e2410998 https:\/\/doi.org\/10.1002\/advs.202410998 (2025).","journal-title":"Adv. Sci."},{"key":"77546_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41588-024-01998-y","volume":"57","author":"Y Yan","year":"2025","unstructured":"Yan, Y. et al. Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer. Nat. Genet. 57, 126\u2013139 https:\/\/doi.org\/10.1038\/s41588-024-01998-y (2025).","journal-title":"Nat. Genet."},{"key":"77546_CR31","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.ccell.2025.03.011","volume":"43","author":"Z Tang","year":"2025","unstructured":"Tang, Z. et al. Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures. Cancer Cell 43, 1025\u20131044.e1014 https:\/\/doi.org\/10.1016\/j.ccell.2025.03.011 (2025).","journal-title":"Cancer Cell"},{"key":"77546_CR32","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ccell.2015.10.012","volume":"28","author":"L Galluzzi","year":"2015","unstructured":"Galluzzi, L., Buque, A., Kepp, O., Zitvogel, L. & Kroemer, G. Immunological effects of conventional chemotherapy and targeted anticancer agents. Cancer Cell 28, 690\u2013714 https:\/\/doi.org\/10.1016\/j.ccell.2015.10.012 (2015).","journal-title":"Cancer Cell"},{"key":"77546_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202405749","volume":"12","author":"Y Huang","year":"2025","unstructured":"Huang, Y. et al. Single-nucleus and spatial transcriptome profiling delineates the multicellular ecosystem in hepatocellular carcinoma after hepatic arterial infusion chemotherapy. Adv. Sci. 12, e2405749 https:\/\/doi.org\/10.1002\/advs.202405749 (2025).","journal-title":"Adv. Sci."},{"key":"77546_CR34","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1158\/1078-0432.CCR-24-1594","volume":"31","author":"T Lanickova","year":"2025","unstructured":"Lanickova, T. et al. Chemotherapy drives tertiary lymphoid structures that correlate with ICI-responsive TCF1+CD8+ T cells in metastatic ovarian cancer. Clin. Cancer Res. 31, 164\u2013180 https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-1594 (2025).","journal-title":"Clin. Cancer Res."},{"key":"77546_CR35","doi-asserted-by":"publisher","unstructured":"Bouvet, M. et al. Multiple viral microRNAs regulate interferon release and signaling early during infection with Epstein-Barr virus. mBio 12, https:\/\/doi.org\/10.1128\/mBio.03440-20 (2021).","DOI":"10.1128\/mBio.03440-20"},{"key":"77546_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107226","volume":"300","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Epstein-Barr virus suppresses N(6)-methyladenosine modification of TLR9 to promote immune evasion. J. Biol. Chem. 300, 107226 https:\/\/doi.org\/10.1016\/j.jbc.2024.107226 (2024).","journal-title":"J. Biol. Chem."},{"key":"77546_CR37","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202050714","volume":"22","author":"X Long","year":"2021","unstructured":"Long, X. et al. BRLF1 suppresses RNA Pol III-mediated RIG-I inflammasome activation in the early EBV lytic lifecycle. EMBO Rep. 22, e50714 https:\/\/doi.org\/10.15252\/embr.202050714 (2021).","journal-title":"EMBO Rep."},{"key":"77546_CR38","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1182\/blood-2014-08-594689","volume":"125","author":"JH Lin","year":"2015","unstructured":"Lin, J. H. et al. Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1. Blood 125, 2228\u20132238 https:\/\/doi.org\/10.1182\/blood-2014-08-594689 (2015).","journal-title":"Blood"},{"key":"77546_CR39","doi-asserted-by":"publisher","first-page":"e1005550","DOI":"10.1371\/journal.ppat.1005550","volume":"12","author":"AM Gram","year":"2016","unstructured":"Gram, A. M. et al. The Epstein-Barr virus glycoprotein gp150 forms an immune-evasive glycan shield at the surface of infected cells. PLoS Pathog. 12, e1005550 https:\/\/doi.org\/10.1371\/journal.ppat.1005550 (2016).","journal-title":"PLoS Pathog."},{"key":"77546_CR40","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1128\/jvi.02183-15","volume":"90","author":"LL Quinn","year":"2016","unstructured":"Quinn, L. L. et al. The missing link in Epstein-Barr virus immune evasion: the BDLF3 gene induces ubiquitination and downregulation of major histocompatibility complex class I (MHC-I) and MHC-II. J. Virol. 90, 356\u2013367 https:\/\/doi.org\/10.1128\/jvi.02183-15 (2016).","journal-title":"J. Virol."},{"key":"77546_CR41","doi-asserted-by":"publisher","first-page":"E6467","DOI":"10.1073\/pnas.1605884113","volume":"113","author":"M Albanese","year":"2016","unstructured":"Albanese, M. et al. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells. Proc. Natl. Acad. Sci. USA 113, E6467\u2013e6475 https:\/\/doi.org\/10.1073\/pnas.1605884113 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77546_CR42","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41375-018-0178-x","volume":"33","author":"E Anastasiadou","year":"2019","unstructured":"Anastasiadou, E. et al. Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas. Leukemia 33, 132\u2013147 https:\/\/doi.org\/10.1038\/s41375-018-0178-x (2019).","journal-title":"Leukemia"},{"key":"77546_CR43","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1158\/0008-5472.Can-20-4321","volume":"81","author":"J Ge","year":"2021","unstructured":"Ge, J. et al. Epstein-Barr virus-encoded circular RNA CircBART2.2 promotes immune escape of nasopharyngeal carcinoma by regulating PD-L1. Cancer Res. 81, 5074\u20135088 https:\/\/doi.org\/10.1158\/0008-5472.Can-20-4321 (2021).","journal-title":"Cancer Res."},{"key":"77546_CR44","doi-asserted-by":"publisher","first-page":"e0021923","DOI":"10.1128\/jvi.00219-23","volume":"97","author":"M Abou Harb","year":"2023","unstructured":"Abou Harb, M., Meckes, D. G. Jr. & Sun, L. Epstein-Barr virus LMP1 enhances levels of large extracellular vesicle-associated PD-L1. J. Virol. 97, e0021923 https:\/\/doi.org\/10.1128\/jvi.00219-23 (2023).","journal-title":"J. Virol."},{"key":"77546_CR45","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.1002\/cam4.3213","volume":"9","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. Mechanisms of Epstein-Barr virus nuclear antigen 1 favor Tregs accumulation in nasopharyngeal carcinoma. Cancer Med. 9, 5598\u20135608 https:\/\/doi.org\/10.1002\/cam4.3213 (2020).","journal-title":"Cancer Med."},{"key":"77546_CR46","doi-asserted-by":"publisher","unstructured":"Huo, S. et al. EBV-EBNA1 constructs an immunosuppressive microenvironment for nasopharyngeal carcinoma by promoting the chemoattraction of Treg cells. J. Immunother. Cancer 8, https:\/\/doi.org\/10.1136\/jitc-2020-001588 (2020).","DOI":"10.1136\/jitc-2020-001588"},{"key":"77546_CR47","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2024.2306795","volume":"15","author":"W Xia","year":"2024","unstructured":"Xia, W., Shi, N., Li, C. & Tang, A. RNA-Seq and miRNA-Seq data from Epstein-Barr virus-infected tree shrews reveal a ceRNA network contributing to immune microenvironment regulation. Virulence 15, 2306795 https:\/\/doi.org\/10.1080\/21505594.2024.2306795 (2024).","journal-title":"Virulence"},{"key":"77546_CR48","first-page":"1920","volume":"62","author":"WH Feng","year":"2002","unstructured":"Feng, W. H., Israel, B., Raab-Traub, N., Busson, P. & Kenney, S. C. Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors. Cancer Res. 62, 1920\u20131926 (2002).","journal-title":"Cancer Res."},{"key":"77546_CR49","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s12272-011-0414-7","volume":"34","author":"JS Seo","year":"2011","unstructured":"Seo, J. S., Kim, T. G., Hong, Y. S., Chen, J. Y. & Lee, S. K. Contribution of Epstein-Barr virus infection to chemoresistance of gastric carcinoma cells to 5-fluorouracil. Arch. Pharm. Res. 34, 635\u2013643 https:\/\/doi.org\/10.1007\/s12272-011-0414-7 (2011).","journal-title":"Arch. Pharm. Res."},{"key":"77546_CR50","doi-asserted-by":"publisher","unstructured":"Morales-Sanchez, A. & Fuentes-Panana, E. M. The immunomodulatory capacity of an Epstein-Barr virus abortive lytic cycle: potential contribution to viral tumorigenesis. Cancers 10, https:\/\/doi.org\/10.3390\/cancers10040098 (2018).","DOI":"10.3390\/cancers10040098"},{"key":"77546_CR51","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2369336","volume":"16","author":"G Wang","year":"2024","unstructured":"Wang, G. et al. Intratumoral microbiome is associated with gastric cancer prognosis and therapy efficacy. Gut Microbes 16, 2369336 https:\/\/doi.org\/10.1080\/19490976.2024.2369336 (2024).","journal-title":"Gut Microbes"},{"key":"77546_CR52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/PAP.0000000000000162","volume":"24","author":"S Hendry","year":"2017","unstructured":"Hendry, S. et al. Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immunooncology Biomarkers Working Group: Part 1: assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research. Adv. Anat. Pathol. 24, 235\u2013251 https:\/\/doi.org\/10.1097\/PAP.0000000000000162 (2017).","journal-title":"Adv. Anat. Pathol."},{"key":"77546_CR53","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41588-024-01664-3","volume":"56","author":"V Singhal","year":"2024","unstructured":"Singhal, V. et al. BANKSY unifies cell typing and tissue domain segmentation for scalable spatial omics data analysis. Nat. Genet. 56, 431\u2013441 https:\/\/doi.org\/10.1038\/s41588-024-01664-3 (2024).","journal-title":"Nat. Genet."},{"key":"77546_CR54","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","volume":"618","author":"A Gavish","year":"2023","unstructured":"Gavish, A. et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature 618, 598\u2013606 https:\/\/doi.org\/10.1038\/s41586-023-06130-4 (2023).","journal-title":"Nature"},{"key":"77546_CR55","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1084\/jem.20090410","volume":"206","author":"CH GeurtsvanKessel","year":"2009","unstructured":"GeurtsvanKessel, C. H. et al. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J. Exp. Med. 206, 2339\u20132349 https:\/\/doi.org\/10.1084\/jem.20090410 (2009).","journal-title":"J. Exp. Med."},{"key":"77546_CR56","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/0046-8177(93)90235-9","volume":"24","author":"RM Genta","year":"1993","unstructured":"Genta, R. M., Hamner, H. W. & Graham, D. Y. Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum. Pathol. 24, 577\u2013583 https:\/\/doi.org\/10.1016\/0046-8177(93)90235-9 (1993).","journal-title":"Hum. Pathol."},{"key":"77546_CR57","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni.3558","volume":"17","author":"Q Chen","year":"2016","unstructured":"Chen, Q., Sun, L. & Chen, Z. J. Regulation and function of the cGAS\u2013STING pathway of cytosolic DNA sensing. Nat. Immunol. 17, 1142\u20131149 https:\/\/doi.org\/10.1038\/ni.3558 (2016).","journal-title":"Nat. Immunol."},{"key":"77546_CR58","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","volume":"185","author":"B Damania","year":"2022","unstructured":"Damania, B., Kenney, S. C. & Raab-Traub, N. Epstein-Barr virus: biology and clinical disease. Cell 185, 3652\u20133670 https:\/\/doi.org\/10.1016\/j.cell.2022.08.026 (2022).","journal-title":"Cell"},{"key":"77546_CR59","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41392-023-01622-1","volume":"8","author":"MZ Qiu","year":"2023","unstructured":"Qiu, M. Z. et al. Dynamic single-cell mapping unveils Epstein\u2012Barr virus-imprinted T-cell exhaustion and on-treatment response. Signal Transduct. Target. Ther. 8, 370 https:\/\/doi.org\/10.1038\/s41392-023-01622-1 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"77546_CR60","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/s41591-024-03450-4","volume":"31","author":"L Shen","year":"2025","unstructured":"Shen, L. et al. First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial. Nat. Med. 31, 1163\u20131170 https:\/\/doi.org\/10.1038\/s41591-024-03450-4 (2025).","journal-title":"Nat. Med."},{"key":"77546_CR61","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/gutjnl-2019-320368","volume":"70","author":"M Zhang","year":"2021","unstructured":"Zhang, M. et al. Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing. Gut 70, 464\u2013475 https:\/\/doi.org\/10.1136\/gutjnl-2019-320368 (2021).","journal-title":"Gut"},{"key":"77546_CR62","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41587-021-01139-4","volume":"40","author":"V Kleshchevnikov","year":"2022","unstructured":"Kleshchevnikov, V. et al. Cell2location maps fine-grained cell types in spatial transcriptomics. Nat. Biotechnol. 40, 661\u2013671 https:\/\/doi.org\/10.1038\/s41587-021-01139-4 (2022).","journal-title":"Nat. Biotechnol."},{"key":"77546_CR63","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41592-021-01255-8","volume":"18","author":"J Hu","year":"2021","unstructured":"Hu, J. et al. SpaGCN: Integrating gene expression, spatial location and histology to identify spatial domains and spatially variable genes by graph convolutional network. Nat. Methods 18, 1342\u20131351 https:\/\/doi.org\/10.1038\/s41592-021-01255-8 (2021).","journal-title":"Nat. Methods"},{"key":"77546_CR64","doi-asserted-by":"publisher","unstructured":"Condamine, T. et al. Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients. Sci. Immunol. 1, https:\/\/doi.org\/10.1126\/sciimmunol.aaf8943 (2016).","DOI":"10.1126\/sciimmunol.aaf8943"},{"key":"77546_CR65","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ajpath.2011.03.007","volume":"179","author":"D Coppola","year":"2011","unstructured":"Coppola, D. et al. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. Am. J. Pathol. 179, 37\u201345 https:\/\/doi.org\/10.1016\/j.ajpath.2011.03.007 (2011).","journal-title":"Am. J. Pathol."},{"key":"77546_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2023.102497","volume":"4","author":"Y Kuang","year":"2023","unstructured":"Kuang, Y., Parthasarathy, U. & Martinelli, R. Protocol for density gradient neutrophil isolation and flow cytometry-based characterization from human peripheral blood. STAR Protoc. 4, 102497 https:\/\/doi.org\/10.1016\/j.xpro.2023.102497 (2023).","journal-title":"STAR Protoc."},{"key":"77546_CR67","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","volume":"19","author":"T Chen","year":"2021","unstructured":"Chen, T. et al. The genome sequence archive family: toward explosive data growth and diverse data types. Genom. Proteom. Bioinform. 19, 578\u2013583 https:\/\/doi.org\/10.1016\/j.gpb.2021.08.001 (2021).","journal-title":"Genom. Proteom. Bioinform."},{"key":"77546_CR68","doi-asserted-by":"publisher","unstructured":"Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2022. Nucleic Acids Res. 50, D27-d38 https:\/\/doi.org\/10.1093\/nar\/gkab951 (2022).","DOI":"10.1093\/nar\/gkab951"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77546-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77546-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77546-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:50:48Z","timestamp":1792709448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77546-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77546"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77546-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"6 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"11060"}}